Beijing Balance Medical Technology Co.,Ltd. (SHA: 688198)

Beijing Balance Medical Technology Co.,Ltd. Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	404.84	369.91	295.07	251.8	181.9	145.97
Other Revenue	0.73	0.73	0.1	0.02	0.02	0.07
Revenue	405.57	370.64	295.17	251.82	181.92	146.03
Revenue Growth (YoY)	22.23%	25.57%	17.21%	38.42%	24.57%	31.98%
Cost of Revenue	44.5	37.64	31.36	29.61	20.21	13.08
Gross Profit	361.07	333	263.81	222.21	161.71	132.95
Selling, General & Admin	129.78	131.97	123.77	131.16	83.41	49.42
Research & Development	144.72	98.81	55.15	58.9	28.77	15.15
Other Operating Expenses	4.25	1.25	1.62	1.17	1.06	0.77
Operating Expenses	279.63	233.5	181.64	192.04	114.69	65.37
Operating Income	81.44	99.5	82.17	30.17	47.02	67.59
Interest Expense	-0.17	-0.41	-0.08	-0.12	-	-
Interest & Investment Income	16.84	17.66	22.53	16.49	19.55	5
Currency Exchange Gain (Loss)	-0.26	-0.26	0	-	-	-
Other Non Operating Income (Expenses)	1.54	-0.06	-0.68	-0.05	-0.06	0
EBT Excluding Unusual Items	99.38	116.43	103.94	46.5	66.51	72.59
Gain (Loss) on Sale of Investments	-1.61	1	0.89	0.97	0.34	-
Gain (Loss) on Sale of Assets	0	0.05	-0.01	-0.02	0.01	0.03
Other Unusual Items	5.29	2.54	1.32	2.31	-0.57	0.32
Pretax Income	103.06	120.02	106.14	49.76	66.29	72.95
Income Tax Expense	12.11	10.61	11.74	-1.51	10.37	10.06
Earnings From Continuing Operations	90.95	109.41	94.39	51.26	55.92	62.89
Minority Interest in Earnings	12.61	5.8	0.73	-0.06	0.61	0.2
Net Income	103.55	115.21	95.13	51.2	56.53	63.08
Net Income to Common	103.55	115.21	95.13	51.2	56.53	63.08
Net Income Growth	-1.96%	21.11%	85.80%	-9.42%	-10.40%	88.88%
Shares Outstanding (Basic)	136	136	136	135	134	100
Shares Outstanding (Diluted)	136	137	136	135	134	100
Shares Change (YoY)	-0.64%	0.92%	0.86%	0.44%	33.66%	15.89%
EPS (Basic)	0.76	0.85	0.70	0.38	0.42	0.63
EPS (Diluted)	0.76	0.84	0.70	0.38	0.42	0.63
EPS Growth	-1.33%	20.00%	84.21%	-9.82%	-32.96%	62.98%
Free Cash Flow	-113.44	12.53	24.01	4.27	43.07	61.86
Free Cash Flow Per Share	-0.83	0.09	0.18	0.03	0.32	0.62
Dividend Per Share	0.800	0.800	0.500	0.357	0.143	0.143
Dividend Growth	60.00%	60.00%	40.02%	149.90%	0%	-49.61%
Gross Margin	89.03%	89.84%	89.38%	88.24%	88.89%	91.04%
Operating Margin	20.08%	26.85%	27.84%	11.98%	25.85%	46.28%
Profit Margin	25.53%	31.08%	32.23%	20.33%	31.07%	43.20%
Free Cash Flow Margin	-27.97%	3.38%	8.14%	1.70%	23.68%	42.36%
EBITDA	96.29	110.4	87.78	36.19	52.69	73.39
EBITDA Margin	23.74%	29.79%	29.74%	14.37%	28.96%	50.26%
D&A For EBITDA	14.85	10.89	5.61	6.02	5.67	5.81
EBIT	81.44	99.5	82.17	30.17	47.02	67.59
EBIT Margin	20.08%	26.85%	27.84%	11.98%	25.85%	46.28%
Effective Tax Rate	11.75%	8.84%	11.06%	-	15.64%	13.79%
Revenue as Reported	113.25	370.64	295.17	251.82	181.92	146.03
Advertising Expenses	-	0.37	1.12	1.22	0.72	1.03

Source: S&P Capital IQ. Standard template. Financial Sources.